Description
Indian Infotech and Software Limited extends its ongoing rights issue closing date from August 20, 2025 to September 2, 2025.
Summary
Indian Infotech and Software Limited (Scrip Code: 509051) has extended the closing date of its ongoing rights issue from August 20, 2025 to September 2, 2025. The Right Issue Committee approved this extension on August 18, 2025, to provide eligible equity shareholders with additional time to apply for the rights offering.
Key Points
- Rights issue originally scheduled to close on August 20, 2025
- New closing date: September 2, 2025
- Issue commenced on August 6, 2025
- No changes to terms and conditions of Letter of Offer (LOF) or Application Form
- Extension approved by Right Issue Committee meeting held on August 18, 2025
- Meeting duration: 2:00 PM to 2:30 PM
Regulatory Changes
No regulatory changes. This is an administrative extension of the rights issue timeline under existing SEBI regulations.
Compliance Requirements
- Addendum to LOF with revised closing date and timeline to be made available on:
- Company website: www.indianinfotechandsoftwareltd.in
- Registrar website: www.purvashare.com
- BSE website: www.bseindia.com
- Disclosure made pursuant to Regulation 30 of SEBI (LODR) Regulations, 2015
Important Dates
- Last date for credit of rights entitlements: July 29, 2025
- Issue Opening Date: August 6, 2025
- Last Date for on Market Renunciation: August 8, 2025
- Revised Issue Closing Date: September 2, 2025
- Finalization of Basis of Allotment: September 3, 2025 (on or about)
- Date of Allotment: September 3, 2025 (on or about)
- Date of listing application to SE: September 3, 2025 (on or about)
- Date of in-principle approval: September 4, 2025 (on or about)
- Date of credit application: September 4, 2025 (on or about)
Impact Assessment
The extension provides eligible shareholders with approximately 13 additional days to participate in the rights issue, potentially improving subscription levels. This is a routine corporate action that demonstrates management’s commitment to maximizing shareholder participation. No material impact on trading or market operations expected, though it extends the timeline for capital infusion into the company.
Impact Justification
Rights issue extension provides additional opportunity for shareholders to participate but represents a routine corporate action